Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on June 4, 2009
J Am Soc Nephrol 20: 2296-2304, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008121230

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008121230v1
20/11/2296    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Rosenstiel, P.
Right arrow Articles by Klotman, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenstiel, P.
Right arrow Articles by Klotman, P.

Brief Reviews

Transgenic and Infectious Animal Models of HIV-Associated Nephropathy

Paul Rosenstiel*, Ali Gharavi{dagger}, Vivette D'Agati{ddagger} and Paul Klotman*

*Department of Medicine, Mount Sinai School of Medicine, and
Departments of {dagger}Medicine and
{ddagger}Pathology, Columbia College of Physicians and Surgeons, New York, New York

Correspondence: Dr. Paul Klotman, Department of Medicine, Mount Sinai School of Medicine, Medicine Box 1118, One Gustave L Levy Place, New York, NY 10029. Phone: 212-241-8807; Fax: 212-876-5844; E-mail: paul.klotman{at}mssm.edu

HIV-associated nephropathy (HIVAN) is a major cause of HIV-related morbidity and mortality. Transgenic and infectious models of HIVAN faithfully recapitulate the human disease and are important tools in advancing our understanding of disease pathogenesis, genetic susceptibility, and therapeutic intervention beyond the inhibition of viral replication. This review discusses the available transgenic murine models and infectious models of HIVAN in mice, rats, nonhuman primates, and felines. Particular emphasis is given to cell type–specific HIV expression as well as partial HIV genome expression used to map HIV-1 Nef and Vpr as pathologic determinants.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP